John Mandrola, MD, Discover and Read the Best of Twitter Threads by @drjohnm

John Mandrola, MD

drjohnm

Honored to moderate #TAVI vs SAVR session at #EACTS2020 Things I learned and worry about: TAVI is an amazing advance. A shining example of clinician-industry collaboration. A less invasive way

Giving talks in which you don't have a slide deck already made is illuminating. Look what I found out about publication bias> It was "discovered" in 1979 by Rosenthal https://content.apa.org/record/1979-27602-001How

Thread: To me, the most stunning report from #ESCCongress thus far: RATE-AF trial Older pts w/ permanent AF + shortness of breath. (there are lots of these pts). Rate control

Proud to co-author a scientific manuscript published on the preprint @medrxivpreprintOn #COVID19 science.The question: How much faster do journals approve/publish COVID papers? Take a guess before reading our research letter

Thread on a potential silver lining of #COVID19 My friend @BenMazer is a pathologist and he's noticed huge declines in specimens obtained for cancer diagnoses. Reason: hospitals have stopped elective

Well, after dismissing the observational trial of remdesivir for #COVID19 last evening. I wake to find a surprise that causes me to relook.@EricTopol, who is an experienced and thoughtful scientist

Paper from Prof. Ioannidis et al. They study the risk of #COVID19 death in younger vs older age groups from hotspot areas across the world. I like this paper

This may be one of the most important pieces of content @medscape has ever published. What if we are doing it wrong in the treatment of #COVID19? What if @cameronks